Philips Launches its First Clinical Product for Aiding Cognitive Assessment in the U.S.

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced the U.S. debut of its new cognitive assessment platform IntelliSpace Cognition. Leveraging the power of artificial intelligence (AI) and Philips' cloud-based HealthSuite Digital Platform, IntelliSpace Cognition provides healthcare professionals with a powerful aid for assessing cognitive impairment.
Source: eHealth News EU - Category: Information Technology Tags: Featured Philips Business and Industry Source Type: news